9家公司首发事项将于本周上会

Core Viewpoint - This week, a total of 9 companies are scheduled for IPO meetings across various stock exchanges, with significant fundraising amounts expected, particularly from Vision Technology, which aims to raise 2.015 billion yuan [1]. Group 1: Upcoming IPOs - Nine companies will present their IPO applications from December 22 to December 26, with the highest fundraising target set by Vision Technology at 2.015 billion yuan [1]. - The companies include: - Fuen Co., Ltd. and Shenglong Co., Ltd. targeting the Shenzhen Main Board [1]. - Vision Technology aiming for the Sci-Tech Innovation Board [1]. - Sanrui Intelligent and Dapu Micro targeting the Growth Enterprise Market [1]. - Xinhengtai and Puan Medical, among others, targeting the Beijing Stock Exchange [1]. Group 2: Fundraising Amounts - Vision Technology plans to use the raised funds for the expansion of its ultra-high-resolution silicon-based OLED micro-display production line and R&D center [1]. - Dapu Micro and Shenglong Co., Ltd. follow with fundraising targets of 1.878 billion yuan and 1.530 billion yuan, respectively [1]. Group 3: Company Profiles - Shenglong Co., Ltd. is a leading large-scale molybdenum company focused on the comprehensive development and utilization of non-ferrous metal mineral resources [2]. - Fuen Co., Ltd. specializes in the research, production, and sales of eco-friendly fabrics [3]. - Dapu Micro is engaged in the research and sales of enterprise-level SSD products for data centers [4]. - Sanrui Intelligent focuses on the R&D, production, and sales of electric power systems for drones and robots [5]. - Vision Technology is a global leader in micro-display solutions, offering silicon-based OLED micro-displays and value-added services [6]. - Ying's Holdings operates in the infant nutrition and care sector, producing a range of baby products [7]. - Longyuan Co., Ltd. specializes in the R&D, production, and sales of aluminum alloy precision die-casting parts [8]. - Puan Medical focuses on the R&D, production, and sales of medical devices for diabetes care and minimally invasive interventions [9]. - Xinhengtai is involved in the R&D, manufacturing, and sales of plastic foaming materials [10].